期刊文献+

三维适形放射治疗中晚期胰腺癌23例近期疗效观察

Tree-Dimensional Conformal Radiotherapy for Advanced with Pancreatic Cancer in 23 Patients
下载PDF
导出
摘要 目的:分析三维适形放射治疗(3-DCRT)中晚期胰腺癌的近期疗效。方法:2002年4月,对23例不能手术的中晚期胰腺癌患者三维适形放疗,采用高剂量低分割的方法。每周3次,3.5 GY^4.5 GY,肿瘤总剂量55 GY^65GY。3个月随访。结果:23例患者均有不同程度的缓解,症状及体征改善明显。CT及MRI复查中,CR 6例,PR 15例,S2例。结论:三维适形放射治疗胰腺癌定位肿瘤准确,重复性好,副反应小,近期疗效较满意,对不能手术的中晚期胰腺癌患者不失为一种有效的治疗方法。 Objective To evaluate the immediate result of 3- dimensional conformal radiotherapy for advanced pancreatic cancer. Methods between April 2002 and April 2004, 23 pancreatic cancer patients with middle or terminal stage were treated by 33-dimensional conformal radiotherapy with high dose and low fraction,third weekly, 3.5 GY 4.5 GY perfection . Tumor total dose conformal radiation 55 GY~65 GY,Resulis CT or MRI examination revealed 6 patients with CR, 15 patients with PR, and 2 patients with S. Conclusions Three -dimensional conformal radiotherapy for pancreatic cancer has the feature of location precision,no side result, satisfaction with immediate result, 3-dimensional conformal radiotherapy treatment was valid method for no-resection pancreatic cancer patient with middle or terminal stage.
出处 《实用医技杂志》 2005年第09A期2335-2336,共2页 Journal of Practical Medical Techniques
关键词 胰腺癌 三维适形放射治疗 近期疗效 Pancreatic cancer 3-dimensional conformal radiotherapy Immedinte result
  • 相关文献

参考文献1

二级参考文献9

  • 1钟守先.积极开展胰头癌根治术——为提高五年生存率而努力[J].中华肝胆外科杂志,1998,4(5):267-268. 被引量:14
  • 2Birgir Gudjonsson. Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. Am Coll Surg, 1995, 181:483-503.
  • 3Adsay NV, Conlon KC, Zee SY, et al. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer, 2002, 94:62-77.
  • 4Bluemke DA, Cameron JL, Hruban RH. Potentially respectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology, 1995, 197:381-385.
  • 5Banfi G, Zerbi A, Pastori S, et al. Behavior of tumor markers. CA19-9, CA195, CAM43, CA242, and TPS in the diagnosis and follow-up of pancreatic cancer. Clin Chem, 1993, 39: 420-423.
  • 6Tian F, Appert HE, Myles J, et al. Prognostic value of serum CA19-9 levels in pancreatic adenocarcinoma. Ann Surg, 1992, 215: 350-355.
  • 7Paulino AC, Latona C. Unresectable adenocarcinoma of the pancreas: patterns of failure and treatment results. Cancer Invest, 2000, 18: 309-313.
  • 8Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas- 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg, 2000, 4: 567-579.
  • 9倪泉兴,张群华,傅德良,曹国海,华鲁纯,姚其远,金忱,虞先浚,张妞,张延龄.中晚期胰头癌的外科切除治疗[J].中华外科杂志,2001,39(7):508-510. 被引量:6

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部